Aug 2026· Frontiers in Immunology· Vol 17· 0 citations· 78 references
Medicine
TL;DR
A comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies are provided to inform future mechanistic studies and facilitate translational advances in targeted therapies.
Abstract
OTU deubiquitinase with linear linkage specificity (OTULIN) is the only deubiquitinase known to exhibit strict specificity for Met1-linked linear ubiquitin chains, serving as a critical regulator that restrains linear ubiquitin chain assembly complex and maintains inflammatory homeostasis and tissue integrity. Advances over recent years have reshaped our understanding of OTULIN from a negative regulator confined to the canonical nuclear factor kappa-light-chain-enhancer of activated B cells pathway to a central editor governing linear ubiquitin network homeostasis. Its functional repertoire spans receptor-proximal inflammatory signaling, cell death fate determination, inflammasome activation, autophagy, and cellular stress adaptation. Emerging evidence from human genetics and animal models has further broadened the OTULIN-associated disease spectrum, revealing that pathogenesis arises from imbalanced linear ubiquitin networks coupled with cell type and tissue context dependent inflammatory dysregulation. Here, we provide a comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies, aiming to inform future mechanistic studies and facilitate translational advances in targeted therapies.
The ubiquitin-proteasome system maintains cellular protein turnover and quality control through the coordinated action of ubiquitin ligases and deubiquitinating enzymes (DUBs). While the functions of E3 ubiquitin ligases have been extensively investigated in renal disease, the ~100 human DUBs distributed across seven s...
Qianqian Li, Yufang Ni, Zhao-Yang Li et al.· Molecular Medicine Reports· 1 citation
A deeper understanding of Odin's structural organization and molecular mechanisms may not only reveal fundamental principles of receptor regulation but also establish Odin as a promising, yet largely unexplored, therapeutic target.
V. Pennacchietti, F. Malagrinò, S. Gianni· Expert opinion on therapeuti...· 0 citations
Ring finger protein 128 (RNF128) belongs to the family of transmembrane E3 ubiquitin (Ub) ligases. It mediates substrate-specific ubiquitination as a critical post-translational modification and regulates diverse physiological activities and pathological processes. More importantly, the E3 Ub ligase RNF128 is involved...
Qiu-Xiang Xiao, Qi-Dong Liu, Jin-Can Wei et al.· Journal of Cancer· 0 citations
It is proposed that UBA1 functions as a proteostasis-innate immunity checkpoint whose biological output is determined by residual enzymatic activity, subcellular distribution, lineage context, and clone size and suggests a mechanism-based approach to therapeutic intervention in VEXAS syndrome and malignancy.
Yan-Yu Zhang, Quan-Xin Su· Frontiers in Immunology· 0 citations
Membrane-associated RING-CH (MARCH) ligases are a family of 11 ubiquitin E3 ligases that regulate protein stability, trafficking, and signaling across diverse cellular contexts. Although MARCH ligases have been studied most extensively in immune regulation, antigen presentation, viral restriction, and cellular homeosta...
S. Speaks, Anthony Pastore, Mu-Chun Tsai· Journal of respiratory biolo...· 0 citations
A20 emerges as a context-dependent regulator of inflammation, tissue remodeling and tumour progression with relevance for biomarker development and precision therapeutic targeting and the therapeutic implications of A20 are assessed.